FDA Commissioner Resigns
Scott Gottlieb, commissioner of the US Food and Drug Administration (FDA), resigned Tuesday, raising questions about the status of cannabidiol (CBD). Recently, Gottlieb told a congressional committee that the FDA was “deeply focused” on finding an appropriate way to handle CBD. Although Congress’ passed the farm bill in late 2018, which seemed to open the door to legal CBD, the DEA still considers nonprescribed CBD to be an illegal Schedule I drug, and many legal scholars caution against assuming that CBD is legal.
